Tag Archives: trophos

January, 2015

  • 16 January

    Roche Expands its Rare Disease Portfolio with Trophos Acquisition

    Swiss drugmaker Roche has signed an agreement to acquire privately-held Trophos for up to $545 million. The acquisition will provide Roche with Trophos’ candidate for the rare and debilitating spinal muscular atrophy (SMA). Trophos’ proprietary screening platform generated olesoxime (TRO19622), which is in mid-stage development for SMA. SMA is a …